#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic lymphocytic leukaemia recurrent Thalassaemia Acute graft versus host disease in skin Solitary fibrous tumour Autoimmune demyelinating disease Pleural mesothelioma Retinal dystrophy Trigeminal neuralgia Immune-mediated myositis Obesity Macular telangiectasia Kaposi's sarcoma Hereditary angioedema with C1 esterase inhibitor deficiency Liposarcoma recurrent ROHHAD syndrome More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma refractory – Trials in Disease Hereditary angioedema – Diagnostics Carcinoid syndrome – Treatment Angiosarcoma – Life with Disease Undifferentiated sarcoma – Trials in Disease Mantle cell lymphoma refractory Lymphatic malformation – Basic Information Sjogren’s syndrome Behcet’s syndrome – Basic Information Basal cell naevus syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lenvatinib Benzyl Alcohol Trometamol Suxamethonium Chloride Dermatophagoides Farinae Utreloxastat CILOSTAZOL Levetiracetam Ocrelizumab Tremelimumab Basiliximab Meloxicam Darbepoetin Alfa VALACICLOVIR HYDROCHLORIDE GSKVX000000030810 Methionine Chlorhexidine Dihydrochloride Tramadol Hydrochloride Mbf-015 Felzartamab More therapies…

    Learn about Your Condition

    Double hit lymphoma Paraganglion neoplasm Cerebrovascular accident Vulval cancer Hypervolaemia Micrographic skin surgery Seasonal allergy Ovarian cancer metastatic Binge eating HIV infection Mitral valve prolapse Hepatocellular carcinoma Vulvovaginal discomfort Tubulointerstitial nephritis Stress cardiomyopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire Rouen

Centre Hospitalier Universitaire Rouen

1 Rue De Germont, Bp 96031, Rouen, 76031, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Lecanemab for Patients with Dominantly Inherited Alzheimer’s Disease to Evaluate Prevention and Progression

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Lecanemab
    France

  • Study on Rituximab and Cyclophosphamide for Patients with Severe Mucous Membrane Pemphigoid

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Mucous membrane pemphigoid
    Investigated Drugs:
    • Lactose
    • Anhydrous Cyclophosphamide
    • Glucose
    France

  • Study Comparing Anakinra and Prednisone for Treating Gout Flare in Patients with Advanced Kidney Disease or Kidney Transplant

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Renal failure
    Investigated Drugs:
    • Anakinra
    • Prednisone
    France

  • Study of Tucidinostat and Nivolumab for Patients with Advanced Melanoma Not Treated with PD-1 or PD-L1 Inhibitors

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Tucidinostat
    • Nivolumab
    Belgium Czechia France Germany Italy Spain

  • Study on the Safety and Effectiveness of Volrustomig with a Drug Combination for Patients with Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Volrustomig
    • Carboplatin
    • Infliximab
    France Greece Italy Portugal Romania Spain

  • Study on Imatinib and Chemotherapy Combination for Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Crisantaspase
    • Hydrocortisone Sodium Succinate
    • Tioguanine
    Austria Belgium Czechia Denmark Finland France +6

  • Study on Stopping Infliximab, Methotrexate, and Azathioprine in Patients with Sarcoidosis in Remission

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Sarcoidosis
    Investigated Drugs:
    • Azathioprine
    • Infliximab
    • Methotrexate
    France

  • Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Asundexian
    • Apixaban
    Austria Belgium Bulgaria Czechia Denmark Estonia +16

  • Study on Monkeypox Virus Disease: Effects of Tecovirimat in Patients with and without Antiviral Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Monkeypox
    Investigated Drugs:
    • Tecovirimat
    Belgium France Ireland Italy The Netherlands Norway +2

  • Weight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Cagrilintide
    • Semaglutide
    Austria Belgium Bulgaria Czechia France Greece +8
Previous Page
1 … 45 46 47 48
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!